WHO ICTRP trial
Use of Tranexamic Acid for Prevention of Postpartum Hemorrhage and Routine Blood…
NCT02453568 · NIH Clinical Trials · Not recruiting
Key facts
| Trial ID | NCT02453568 |
|---|---|
| Public title | Use of Tranexamic Acid for Prevention of Postpartum Hemorrhage and Routine Blood Loss in Obstetrics |
| Scientific title | Use of Tranexamic Acid for Prevention of Postpartum Hemorrhage and Routine Blood Loss in Obstetrics |
| Primary sponsor | New York University School of Medicine |
| Registry | NIH Clinical Trials |
| Recruitment status | Not recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Conditions | Uterine Hemorrhage;Uterine Hemorrhage |
| Interventions | Drug: Tranexamic Acid;Drug: Oxytocin;Drug: Placebo;Drug: Tranexamic Acid;Drug: Oxytocin;Drug: Placebo |
| Registration date | May 18, 2015 |
| Target size | 500 |
| Secondary IDs | TxA;TxA |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: